Daphne Wacasey
Psychiatric/Mental Health · Smyrna, GANPI 1720227382
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.0% of the total across 274 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,573 and has fallen 56.1% since, to $690 in 2025. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 274 payments — averaging $21.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$578
- Corium, LLC$515
- AbbVie$475
- Otsuka America Pharmaceutical, Inc.$429
- Takeda Pharmaceuticals U.S.A., Inc.$359
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,47192%
- Education$4768%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 55 | $1,293 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $578 |
| Corium, LLC | 21 | $515 |
| AbbVie | 26 | $475 |
| Otsuka America Pharmaceutical, Inc. | 18 | $429 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $359 |
| Lundbeck LLC | 15 | $316 |
| Johnson & Johnson | 14 | $305 |
| Supernus Pharmaceuticals, Inc. | 14 | $267 |
| Neurocrine Biosciences, Inc. | 9 | $204 |
| Neos Therapeutics, LP | 8 | $152 |
| Alkermes, Inc. | 6 | $145 |
| Sunovion Pharmaceuticals Inc. | 7 | $133 |
| Vanda Pharmaceuticals Inc. | 6 | $115 |
| Bausch Health US, LLC | 7 | $108 |
| Axsome Therapeutics, Inc. | 3 | $84 |
| Idorsia Pharmaceuticals US Inc | 4 | $79 |
| Noven Therapeutics, LLC | 4 | $79 |
| Merck | 4 | $66 |
| Ironshore Pharmaceuticals Inc. | 2 | $37 |
| Tris Pharma Inc | 2 | $36 |
| Neuronetics, Inc. | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Noven Pharmaceuticals, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Almatica Pharma LLC | 1 | $21 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,947 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 12 | $4,302 |
| Quetiapine Fumarate | 50 | $1,162 |
| Olanzapine | 64 | $1,135 |
| Oxcarbazepine | 18 | $924 |
| Benztropine Mesylate | 29 | $733 |
| Fluvoxamine Maleate | 12 | $500 |
| Haloperidol | 23 | $472 |
| Fluoxetine Hcl | 20 | $394 |
| Clonazepam | 41 | $359 |
| Lithium Carbonate | 24 | $155 |
| Risperidone | 32 | $134 |
| Citalopram HbrCitalopram Hydrobromide | 22 | $113 |
| Clonidine Hcl | 28 | $86 |
| Lamotrigine | 12 | $79 |
| Hydroxyzine Hcl | 11 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $21 | $3413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Smyrna
- Olufunke AdewunmiSmyrna$13K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Bradley MosherSuwanee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.